Clinical Trial

Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus

Name: Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus — clinical trial record (NCT07193459)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study, which aims to provide data on the efficacy and safety of HDM1002 tablets in adults with type 2 diabetes mellitus (T2DM) inadequately controlled with diet and exercise only

Trial Details

NCT Number	NCT07193459
Lead Sponsor	Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Conditions	Type 2 Diabetes
Enrollment	360 participants
Start Date	2025-08-12
Primary Completion	2026-10-10 (estimated)
Study Completion	2027-02-01 (estimated)
Updated on ClinicalTrials.gov	2025-09-25